ETRADE Capital Management LLC cut its holdings in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 24.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,640 shares of the software maker’s stock after selling 9,980 shares during the period. ETRADE Capital Management LLC’s holdings in Allscripts Healthcare Solutions were worth $446,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Fuller & Thaler Asset Management Inc. lifted its holdings in Allscripts Healthcare Solutions by 1.0% in the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 5,062,035 shares of the software maker’s stock worth $72,033,000 after purchasing an additional 49,823 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Allscripts Healthcare Solutions by 30.1% in the 3rd quarter. Principal Financial Group Inc. now owns 1,003,690 shares of the software maker’s stock worth $14,283,000 after purchasing an additional 232,209 shares in the last quarter. Neuberger Berman Group LLC lifted its holdings in Allscripts Healthcare Solutions by 5.5% in the 3rd quarter. Neuberger Berman Group LLC now owns 3,676,088 shares of the software maker’s stock worth $52,311,000 after purchasing an additional 190,158 shares in the last quarter. Janney Montgomery Scott LLC purchased a new position in Allscripts Healthcare Solutions in the 3rd quarter worth approximately $710,000. Finally, Cubist Systematic Strategies LLC lifted its holdings in Allscripts Healthcare Solutions by 67,189.1% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 30,953 shares of the software maker’s stock worth $440,000 after purchasing an additional 30,907 shares in the last quarter.
In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $14.26, for a total value of $213,900.00. Following the completion of the sale, the president now directly owns 1,351,773 shares in the company, valued at approximately $19,276,282.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $14.35, for a total value of $71,750.00. Following the completion of the sale, the executive vice president now owns 191,607 shares of the company’s stock, valued at $2,749,560.45. The disclosure for this sale can be found here. Corporate insiders own 0.91% of the company’s stock.
MDRX has been the topic of a number of research analyst reports. Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 price target on shares of Allscripts Healthcare Solutions in a report on Monday, January 8th. Zacks Investment Research cut Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a report on Friday, January 12th. Maxim Group reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Tuesday, January 9th. BidaskClub raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, December 20th. Finally, Wells Fargo & Co set a $19.00 price objective on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Saturday, February 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the company. Allscripts Healthcare Solutions currently has an average rating of “Buy” and a consensus price target of $16.09.
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) opened at $14.04 on Tuesday. The company has a market capitalization of $2,488.51, a price-to-earnings ratio of 29.28, a price-to-earnings-growth ratio of 1.78 and a beta of 1.20. The company has a debt-to-equity ratio of 1.33, a current ratio of 0.97 and a quick ratio of 0.97. Allscripts Healthcare Solutions Inc has a 12-month low of $11.25 and a 12-month high of $16.13.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings data on Thursday, February 15th. The software maker reported $0.18 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. The company had revenue of $547.00 million for the quarter, compared to the consensus estimate of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. Allscripts Healthcare Solutions’s quarterly revenue was up 27.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.14 EPS. equities research analysts expect that Allscripts Healthcare Solutions Inc will post 0.56 earnings per share for the current fiscal year.
WARNING: “Allscripts Healthcare Solutions Inc (MDRX) Shares Sold by ETRADE Capital Management LLC” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/03/20/allscripts-healthcare-solutions-inc-mdrx-shares-sold-by-etrade-capital-management-llc.html.
Allscripts Healthcare Solutions Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.